Archive for the 'Liver Disease' Category
60% Rise In Deaths From Liver Disease In Last Decade: Hepatitis C Is An Increasing Contributor
Huge variations in hepatitis C services in hospitals across the country are revealed in a new report by the All-Party Parliamentary Hepatology Group and The Hepatitis C Trust. In The Dark found widely differing policies on who should receive treatment and the level of specialist support and care available. Hepatitis C is a preventable and treatable blood-borne virus…Original post by Pharmalot
No commentsSuccessful Completion Of First Clinical Trials On Potent New Hepatitis C Drug
The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed…Original post by The Health Wisdom Blog™ (by OrganizedWisdom)
No commentsNIH Awards $1.2 Million To Study Protein Misfolding Diseases
Three University of Massachusetts Amherst scientists have received a four-year, $1.2 million EUREKA grant from the U.S. National Institutes of Health (NIH) to study folding and misfolding of secretory proteins in the cell’s protein factory, the endoplasmic reticulum, where misfolding can lead to diseases such as cystic fibrosis and liver cirrhosis…Original post by Lemonade Life
No commentsNew Partnership Forms To Address The Hepatitis B And C Epidemic In Europe
At least 23 million European Union (EU) citizens are currently living with hepatitis B or hepatitis C,[i] both cancer-causing viruses…Original post by Lemonade Life
No commentsInhibitex Successfully Completes Phase 1a Trial Of INX-189
Inhibitex, Inc. (Nasdaq: INHX), announced that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo…Original post by Lemonade Life
No commentsAbbott Receives FDA Approval For First Automated Molecular Test For Assessing Hepatitis B Treatment
Abbott (NYSE: ABT) announced it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient’s blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results…Original post by Lemonade Life
No commentsBeaumont Hospitals Launches New Liver Transplant Program
Beaumont Hospital, Royal Oak became Michigan’s third liver transplant center on Aug. 31. A 59-year-old man from Royal Oak was the first patient to receive a liver transplant through Beaumont’s new multi-organ transplant program. Under the leadership of Alan J. Koffron, M.D…Original post by Lemonade Life
No commentsInnovative Low Cost, High-Speed Filter Uses Electrified Nanostructures To Purify Water
By dipping plain cotton cloth in a high-tech broth full of silver nanowires and carbon nanotubes, Stanford researchers have developed a new high-speed, low-cost filter that could easily be implemented to purify water in the developing world. Instead of physically trapping bacteria as most existing filters do, the new filter lets them flow on through with the water…Original post by Pharmalot
No commentsBleeding In Cirrhosis Patients May Be Reduced By Adherence To Practice Guidelines
Compliance with practice guideline-recommended treatment for cirrhosis is associated with a reduction in first esophageal variceal hemorrhage (EVH; bleeding), according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. Cirrhosis is a condition in which the liver is permanently scarred or injured…Original post by Pharmalot
No comments